Mosaic Company (The) stocks have been trading up by 7.59 percent following upbeat fertilizer demand outlook and pricing momentum.
What Traders Need To Know
- RBC Capital upgraded Mosaic to Outperform from Sector Perform with a $27 target, calling current phosphate margin pressure temporary and expecting recovery and stronger free cash flow into 2027.
- BMO kept an Outperform rating but cut its target to $31, framing current negative sentiment and margin swings as an attractive entry setup for patient traders.
- A new U.S.–China deal adds at least $17B a year of U.S. ag purchases from 2026–2028, likely boosting fertilizer demand for major players including Mosaic Company (The).
- BNP Paribas cut its target to $30 but maintained Outperform, with shares at $23.52 and still below both its target and the $26.37 Street average, as the stock jumped roughly 4% on the day.
- Multiple firms, including Wells Fargo, Scotiabank and Barclays, trimmed price targets but left ratings at Overweight, Sector Outperform or Equalweight, with consensus targets still clustered in the mid‑$20s above recent prices.
Weekly Update Jun 08 – Jun 12, 2026: On Friday, June 12, 2026 Mosaic Company (The) stock [NYSE: MOS] is trending up by 7.59%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Materials industry expert:
Analyst sentiment – positive
Mosaic remains a scale phosphate and potash producer with clear asset depth but currently subpar fundamentals. Revenue of ~$12.1B is shrinking (3‑yr CAGR -12.9%) and Q1 showed a steep operating loss with EBITDA of $142M and negative FCF of ~$253M, underscoring margin compression versus a 15.7% historical EBITDA margin. Net leverage is moderate (D/E 0.5x, interest cover 11x), liquidity is tight (current ratio 1.3x, quick 0.1x). A 4.2% dividend yield is superficially attractive but covered by balance sheet, not earnings.
Technically, MOS has reversed sharply from a low near $19.85 on June 10 to $22.72 on June 12, breaking short‑term resistance around $21 on strong volume, confirming a near‑term bullish reversal within a broader multi‑month base. Intraday 5‑minute action shows higher lows and sustained bids above $21, indicating real buying rather than a short squeeze only. Actionable level: $21.00–21.20 is now key support; a pullback into that zone is a buy with a tactical stop below $20.50.
Near‑term catalysts are constructive: China’s $17B/year U.S. ag purchase framework lifts fertilizer demand expectations, while multiple upgrades (RBC, BMO, BNP, Scotiabank) highlight that current depressed phosphate margins and sentiment are cyclically low. Versus Materials and Ag peers, MOS trades cheaply at ~0.6x sales and ~0.63x book, with consensus targets clustered around $26–27. I see a 12‑18 month target of $27, with support at $21 and resistance at $25, then $28.
More Breaking News
- Lemonade (LMND) Jumps As Autonomous Car Push Fuels Rally
- AAOI Stock Surges As Insider Selling And ETF Launch Stir Volatility
- CPNG Stock Dips As Coupang Tightens Margins And Cash
- CHSN Stock Pops On Volatile Spike As Traders Circle
Quick Financial Overview
Mosaic Company (The) is trading in the low‑$20s, with recent weekly action showing a bounce from around $19.94 back up toward $22.72. That push higher lines up with analyst commentary highlighting the stock’s discount to mean targets around the mid‑$20s. On the intraday tape, MOS spent most of the session grinding between $22.50 and $22.75, with buyers defending dips and closing the day near the highs, which is constructive short‑term price action.
Under the hood, the business is in a margin trough. Revenue sits around $12.05B, but recent quarterly results show negative net income and an operating loss, reflected in a very high headline P/E near 166 that traders should treat as distorted. Profitability metrics such as an EBITDA margin near 15.7% and gross margin around 13.3% show there is earning power, but current conditions and special items are pressuring reported earnings.
On valuation, MOS trades at roughly 0.6x sales and about 0.63x book value, which is low for a cyclical name with normalized profitability. Balance sheet metrics are reasonable, with total debt‑to‑equity near 0.5 and interest coverage around 11, suggesting no immediate solvency stress. The cash flow statement is messy this quarter, with negative free cash flow of about -$252.6M, but analysts like RBC and BMO are explicitly framing this as cyclical and see free cash flow improving into 2027. A roughly 4.2% dividend yield, backed by a $0.88 annual payout, adds a carry component that some swing traders may factor into multi‑month holds.
Conclusion
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



Leave a reply